Table 3 Analysis of serum apoA-I between male and female patients in different diseases.
Group |  | Mean age ± SD (years) | apoA-I(g/L) | P |
|---|---|---|---|---|
MS | Male (n = 28) | 36.0 ± 15.6 | 1.2620.087 | 0.033* |
|  | Female (n = 32) | 35.7 ± 14.2 | 1.5230.082 |  |
CIS | Male (n = 38) | 40.7 ± 18.5 | 1.4070.082 | 0.082 |
|  | Female (n = 19) | 31.2 ± 17.3 | 1.3700.082 |  |
GBS | Male (n = 28) | 39.9 ± 19.7 | 1.2650.086 | 0.876 |
|  | Female (n = 10) | 29.6 ± 19.9 | 1.2880.116 |  |
viral encephalitis | Male (n = 25) | 30.1 ± 13.8 | 1.0760.060 | 0.080 |
|  | Female (n = 26) | 27.2 ± 13.6 | 1.2210.058 |  |
SLE | Male (n = 14) | 31.9 ± 13.7 | 0.9840.067 | 0.296 |
|  | Female (n = 22) | 31.4 ± 8.57 | 0.8930.053 |  |
RA | Male (n = 15) | 37.9 ± 12.1 | 0.9480.049 | 0.012* |
|  | Female (n = 20) | 35.1 ± 7.75 | 1.1200.042 |  |
Healthy controls | Male (n = 32) | 33.8 ± 4.11 | 1.1170.075 | 0.277 |
|  | Female (n = 27) | 38.1 ± 14.3 | 1.2410.082 |  |